Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.
作者信息
Yubero-Serrano Elena M, Alcalá-Diaz Juan F, Gutierrez-Mariscal Francisco M, Arenas-de Larriva Antonio P, Peña-Orihuela Patricia J, Blanco-Rojo Ruth, Martinez-Botas Javier, Torres-Peña Jose D, Perez-Martinez Pablo, Ordovas Jose M, Delgado-Lista Javier, Gómez-Coronado Diego, Lopez-Miranda Jose
机构信息
Lipids and Atherosclerosis Unit. Servicio de Medicina Interna, Reina Sofia University Hospital, Maimonides Institute for Biomedical Research in Córdoba, University of Córdoba, Córdoba, Spain.
CIBER Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III, Madrid, Spain.
出版信息
Cardiovasc Diabetol. 2021 Apr 17;20(1):79. doi: 10.1186/s12933-021-01269-8.
Abstract
摘要
相似文献
1
Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.对《冠心病合并或不合并2型糖尿病患者胆固醇流出能力与外周动脉疾病之间的关联：来自CORDIOPREV研究》的更正
Cardiovasc Diabetol. 2021 Apr 17;20(1):79. doi: 10.1186/s12933-021-01269-8.
2
Cholesterol efflux capacity is an independent predictor of all-cause and cardiovascular mortality in patients with coronary artery disease: A prospective cohort study.胆固醇流出能力是冠心病患者全因死亡率和心血管死亡率的独立预测指标：一项前瞻性队列研究。
Atherosclerosis. 2016 Jun;249:116-24. doi: 10.1016/j.atherosclerosis.2015.10.111. Epub 2015 Nov 10.
3
Cholesterol efflux capacity in vitro predicts the severity and extent of coronary artery disease in patients with and without type 2 diabetes.体外胆固醇流出能力可预测2型糖尿病患者和非2型糖尿病患者冠状动脉疾病的严重程度和范围。
Scand Cardiovasc J. 2001 Mar;35(2):96-100. doi: 10.1080/140174301750164736.
4
Significance of the percentage of cholesterol efflux capacity and total cholesterol efflux capacity in patients with or without coronary artery disease.胆固醇流出能力百分比和总胆固醇流出能力在有或无冠状动脉疾病患者中的意义。
Heart Vessels. 2017 Jan;32(1):30-38. doi: 10.1007/s00380-016-0837-7. Epub 2016 Apr 22.
5
Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration.患有冠状动脉内皮功能障碍的患者胆固醇流出能力受损，高密度脂蛋白颗粒浓度降低。
Circ Res. 2016 Jun 24;119(1):83-90. doi: 10.1161/CIRCRESAHA.116.308357. Epub 2016 Apr 25.
6
Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis.类风湿关节炎中富含高密度脂蛋白血清的净胆固醇流出能力与冠状动脉粥样硬化
IJC Metab Endocr. 2016 Dec;13:6-11. doi: 10.1016/j.ijcme.2016.08.002. Epub 2016 Aug 28.
7
High-Density Lipoprotein Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk.高密度脂蛋白颗粒、细胞胆固醇外流与冠心病风险
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2007-2015. doi: 10.1161/ATVBAHA.118.311117.
8
High-density lipoprotein cholesterol efflux capacity as a relevant predictor of atherosclerotic coronary disease.高密度脂蛋白胆固醇流出能力作为动脉粥样硬化性冠心病的相关预测指标。
Atherosclerosis. 2015 Sep;242(1):318-22. doi: 10.1016/j.atherosclerosis.2015.06.028. Epub 2015 Jul 13.
9
Association between cholesterol efflux capacity and coronary restenosis after successful stent implantation.成功植入支架后胆固醇流出能力与冠状动脉再狭窄之间的关联。
Heart Vessels. 2016 Aug;31(8):1257-65. doi: 10.1007/s00380-015-0738-1. Epub 2015 Sep 4.
10
Correction: Mediterranean diet as a strategy for preserving kidney function in patients with coronary heart disease with type 2 diabetes and obesity: a secondary analysis of CORDIOPREV randomized controlled trial.更正：地中海饮食作为冠心病合并2型糖尿病和肥胖患者肾功能保护策略：CORDIOPREV随机对照试验的二次分析。
Nutr Diabetes. 2024 Jun 12;14(1):44. doi: 10.1038/s41387-024-00304-3.
本文引用的文献
1
Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study.在伴有和不伴有 2 型糖尿病的冠心病患者中，胆固醇流出能力与外周动脉疾病之间的关系：来自 CORDIOPREV 研究。
Cardiovasc Diabetol. 2021 Mar 25;20(1):72. doi: 10.1186/s12933-021-01260-3.
Zotero 插件